Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PID1 contributors: mct - updated : 22-10-2011
HGNC name phosphotyrosine interaction domain containing 1
HGNC id 26084
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
4 - 2768 28 248 - 2006 16815647
3 - 2450 - 250 predominantly in adipose, also in heart and skeletal muscle 2006 16815647
3 - 2557 - 217 - 2006 16815647
4 - 2664 - 203 - 2006 16815647
2 - 2410 - 168 - 2006 16815647
EXPRESSION
Type
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Connectiveadipose   
Muscularstriatumskeletal  
cell lineage
cell lines
fluid/secretion
at STAGE
cell cycle     cell cycle, checkpoint, G1S
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
phosphotyrosine-binding domain (PTB)
HOMOLOGY
Homologene
FAMILY
CATEGORY regulatory
SUBCELLULAR LOCALIZATION     intracellular
intracellular,cytoplasm
basic FUNCTION
  • increasing proliferation of preadipocytes
  • regulates the functions of IR-1 and AKT1, decreases SLC2A4 translocation and reduces glucose uptake in response to insulin
  • may be an important mediator in the development of obesity-related insulin resistance
  • involved in obesity-associated insulin resistance
  • regulatory function in adipocyte insulin sensitivity
  • potential role in glucose homeostasis and the development of insulin resistance in obesity
  • PID1 is a potent intracellular inhibitor of insulin signaling pathway during obesity
  • PID1 may likely have a tumor inhibitory function in these pediatric and adult brain tumors
  • PID1 serves as an insulin-regulated retention adaptor protein controlling translocation of LRP1 in conjunction with SLC2A4 to the plasma membrane of adipocytes
  • PID1 in adipose tissue increases lipolysis by altering the antilipolytic action of insulin
  • CELLULAR PROCESS cell cycle, checkpoint
    cell life, proliferation/growth
    PHYSIOLOGICAL PROCESS development
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • PID1 serves as a cytosolic adaptor protein of the LDL receptor-related protein 1 (LRP1)
  • by acting as an insulin-dependent retention adaptor, PID1 serves as a regulator of LRP1 function controlling the disposal of postprandial lipoproteins
  • cell & other adipocytes and preadipocytes cells
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway
    constitutional     --over  
    in the adipose tissue of obese subjects
    tumoral     --low  
    in glioblastomas (GBM)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    diabetetype 2 
    may represent a new therapeutic target to ameliorate adipocyte lipolysis and hence improve insulin sensitivity
    ANIMAL & CELL MODELS